Nkarta, Inc.
NKTX
Dr. Nadir
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Nadir
Nkarta, Inc. reported in an 8-K filed March 30, 2023 that Dr. Nadir resigned as Chief Financial and Business Officer, effective June 30, 2023. The proxy statement of Nkarta, Inc. reports total compensation of $2,548,843 for Dr. Nadir in fiscal 2021, including a base salary of $416,100. Disclosed compensation is on record for 2 fiscal years.
“On March 28, 2023, Dr. Nadir Mahmood notified Nkarta, Inc. (the "Company") of his decision to resign as Chief Financial and Business Officer of the Company to take a position as chief executive officer of a private biotechnology company. Dr. Mahmood's resignation is effective June 30, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nkarta, Inc. (NKTX)
Proxy statement
Start not stated–2023-06-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Nkarta, Inc. (NKTX) | Mahmood Chief Financial and Business Officer | $416,100 | $2,548,843 |
| 2020 | Nkarta, Inc. (NKTX) | Mahmood Chief Financial and Business Officer | $348,615 | $2,374,379 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.